Proofpoint Announces Fourth Quarter and Full Year 2016

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
54
Proofpoint Announces Fourth Quarter and Full Year 2016 Financial Results

Fourth Quarter Highlights

  • Total revenue of $106.8 million, up 43% year-over-year
  • Billings of $138.4 million, up 42% year-over-year
  • GAAP EPS of $(0.54) per share, Non-GAAP EPS of $0.18 per share
  • Generated operating cash flow of $41.2 million and free cash flow of $32.4 million
  • Increasing FY17 billings, revenue, profitability and free cash flow guidance

SUNNYVALE, Calif., Jan. 26, 2017 (GLOBE NEWSWIRE) -- Proofpoint, Inc. (NASDAQ: PFPT ), a leading next-generation security and compliance company, today announced financial results for the fourth quarter and full year ended December 31, 2016.

“We were very pleased with our strong fourth quarter results, which capped off another record year for the company,” stated Gary Steele, chief executive officer of Proofpoint.  “During the quarter, the better-than-expected results were driven by the ongoing robust demand for our advanced threat solutions, high competitive win rates, traction with new products, robust add-on activity and consistently high renewal rates.  The company remains well-positioned to maintain momentum in 2017 and beyond as enterprises continue to select Proofpoint’s cloud-based advanced threat protection solution over legacy alternatives, given our proven capability in handling today’s advanced security threats.”

Fourth Quarter 2016 Financial Highlights

  • Revenue : Total revenue for the fourth quarter of 2016 was $106.8 million, an increase of 43% compared to $74.9 million for the fourth quarter of 2015.
  • Billings : Total billings were $138.4 million for the fourth quarter of 2016, an increase of 42% compared to $97.5 million for the fourth quarter of 2015.
  • Gross Profit: GAAP gross profit for the fourth quarter of 2016 was $77.0 million compared to $51.0 million for the fourth quarter of 2015.  Non-GAAP gross profit for the fourth quarter of 2016 was $82.3 million compared to $54.9 million for the fourth quarter of 2015.  GAAP gross margin for the fourth quarter of 2016 was 72% compared to 68% for the fourth quarter of 2015.  Non-GAAP gross margin was 77% for the fourth quarter of 2016 compared to 73% for the fourth quarter of 2015.
  • Operating Income (Loss) : GAAP operating loss for the fourth quarter of 2016 was $(16.1) million compared to a loss of $(21.0) million for the fourth quarter of 2015.  Non-GAAP operating profit for the fourth quarter of 2016 was $9.9 million compared to $1.0 million for the fourth quarter of 2015.
  • Net Income (Loss): GAAP net loss for the fourth quarter of 2016 was $(22.9) million, or $(0.54) per share, based on 42.6 million weighted average shares outstanding.  This compares to a GAAP net loss of $(27.4) million, or $(0.68) per share, based on 40.5 million weighted average shares outstanding for the fourth quarter of 2015. Non-GAAP net profit for the fourth quarter of 2016 was $8.5 million, or $0.18 per share, based on 54.4 million weighted average diluted shares outstanding.  This compares to a non-GAAP net loss of $(0.4) million, or $(0.01) per share, based on 40.5 million weighted average diluted shares outstanding for the fourth quarter of 2015.  Non-GAAP earnings per share for the fourth quarter of 2016 included the shares associated with the company’s convertible notes, and cash interest expense (net of tax) of $1.1 million was added back to net income as the “If-Converted” threshold during the period was achieved.
  • Adjusted EBITDA : Adjusted EBITDA for the fourth quarter of 2016 was $14.8 million compared to $4.6 million for the fourth quarter of 2015.
  • Cash and Cash Flow : As of December 31, 2016, Proofpoint had cash, cash equivalents and short term investments of $396.8 million.  The company generated $41.2 million in net cash from operations for the fourth quarter of 2016 compared to $8.2 million during the fourth quarter of 2015.  The company’s free cash flow for the quarter was $32.4 million compared to $0.5 million for the fourth quarter of 2015.

“We were very pleased with our strong fourth quarter execution, particularly our ability to surpass $100 million in quarterly revenue while generating record free cash flow,” stated Paul Auvil, chief financial officer of Proofpoint.  “During 2016, we delivered billings growth of 43%, revenue growth of 41% and nearly tripled free cash flow.”

Full Year 2016 Financial Highlights

  • Revenue : Total revenue for the full year of 2016 was $375.5 million, an increase of 41% compared to $265.4 million in 2015.
  • Billings : Total billings for the full year of 2016 were $462.8 million, an increase of 43% compared to $324.3 million in 2015.
  • Gross Profit: GAAP gross profit for the full year of 2016 was $266.9 million compared to $181.3 million for 2015.  Non-GAAP gross profit for the full year of 2016 was $285.2 million compared to $194.5 million for 2015.  GAAP gross margin for the full year of 2016 was 71% compared to 68% for 2015.  Non-GAAP gross margin was 76% for the full year of 2016 compared to 73% for 2015.
  • Operating Income (Loss) : GAAP operating loss for the full year of 2016 was $(85.6) million compared to a loss of $(78.2) million for 2015.  Non-GAAP operating profit for the full year of 2016 was $21.6 million compared to a loss of $(0.3) million for 2015.
  • Net Income (Loss): GAAP net loss for the full year of 2016 was $(111.2) million, or $(2.66) per share, based on 41.9 million weighted average shares outstanding.  This compares to a GAAP net loss of $(98.7) million, or $(2.48) per share, based on 39.8 million weighted average shares outstanding for 2015. Non-GAAP net profit for the full year of 2016 was $16.9 million, or $0.37 per share, based on 45.8 million weighted average diluted shares outstanding.  This compares to a non-GAAP net loss of $(6.1) million, or $(0.15) per share, based on 39.8 million weighted average diluted shares outstanding for 2015.  Non-GAAP earnings per share for the full year of 2016 excluded the shares associated with the company’s convertible notes since the “If-Converted” threshold during the period was not achieved.
  • Adjusted EBITDA : Adjusted EBITDA for the full year of 2016 was $38.7 million compared to $12.3 million for 2015.
  • Cash Flow : The company generated $94.2 million in net cash from operations for the full year of 2016 compared to $46.5 million during 2015.  The company generated free cash flow of $59.8 million for the full year of 2016 compared to $20.7 million during 2015.

A reconciliation of GAAP to non-GAAP financial measures has been provided in the financial tables included in this press release.  An explanation of these measures and how they are calculated are also included below under the heading “Non-GAAP Financial Measures.”

Fourth Quarter and Recent Business Highlights:

  • Achieved Federal Risk and Authorization Management Program (FedRAMP) certification for Proofpoint’s cloud-based information archiving solution.
  • Closed the acquisition of FireLayers, an innovator in cloud security, which will extend Proofpoint’s Targeted Attack Protection to SaaS applications enabling customers to protect their employees using SaaS applications from advanced malware.
  • Positioned in the Leaders quadrant of Gartner’s 2016 Magic Quadrant for Enterprise Information Archiving for the fifth consecutive year.

Financial Outlook

As of January 26, 2017, Proofpoint is providing guidance for its first quarter and increasing full year 2017 guidance as follows:

  • First Quarter 2017 Guidance : Total revenue is expected to be in the range of $109.0 million to $111.0 million.  Billings are expected to be in the range of $133.0 million to $135.0 million.  GAAP loss is expected to be in the range of $(31.6) million to $(28.5) million, or $(0.73) to $(0.66) per share, based on approximately 43.2 million weighted average diluted shares outstanding.  Non-GAAP net income is expected to be in the range of $3.0 to $4.0 million, or $0.07 to $0.09 per share, using 54.7 million weighted average diluted shares outstanding, and adding back the $1.1 million in cash interest expense as prescribed under the “If-Converted” method.  Free cash flow is expected to be in the range of $15.0 million to $20.0 million.
  • Full Year 2017 Guidance : Total revenue is expected to be in the range of $488.0 million to $492.0 million.  Billings are expected to be in the range of $611.0 million to $615.0 million.  GAAP loss is expected to be in the range of $(121.4) million to $(113.3) million, or $(2.75) to $(2.57) per share, based on approximately 44.1 million weighted average diluted shares outstanding.  Non-GAAP net income is expected to be in the range of $23.0 to $25.0 million, or $0.49 to $0.52 per share, using 55.7 million weighted average diluted shares outstanding, and adding back the $4.2 million in cash interest expense as prescribed under the “If-Converted” method.  Free cash flow is expected to be in the range of $95.0 million to $105.0 million, which assumes capital expenditures of $40.0 million to $42.0 million for the full year. 

Quarterly Conference Call

Proofpoint will host a conference call today at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to review the company’s financial results for the fourth quarter ended December 31, 2016.  To access this call, dial (888) 204-4517 for the U.S. or Canada and (913) 312-0644 for international callers with conference ID #7351005.  A live webcast of the conference call will be accessible from the Investors section of Proofpoint’s website at investors.proofpoint.com , and a recording will be archived and accessible at investors.proofpoint.com .  An audio replay of this conference call will also be available through February 9, 2017, by dialing (844) 512-2921 for the U.S. or Canada or (412) 317-6671 for international callers, and entering passcode #7351005.

About Proofpoint, Inc.

Proofpoint Inc. (NASDAQ: PFPT ) is a leading next-generation security and compliance company that provides cloud-based solutions to protect the way people work today. Proofpoint solutions enable organizations to protect their users from advanced attacks delivered via email, social media and mobile apps, protect the information their users create from advanced attacks and compliance risks, and respond quickly when incidents occur. More information is available at www.proofpoint.com .

Proofpoint is a trademark or registered trademark of Proofpoint, Inc. in the U.S. and other countries. All other trademarks contained herein are the property of their respective owners.

Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties. These forward-looking statements include statements regarding momentum in the company’s business, market position, win rates and renewal rates, future growth, and future financial results. It is possible that future circumstances might differ from the assumptions on which such statements are based. Important factors that could cause results to differ materially from the statements herein include: failure to maintain or increase renewals and increased business from existing customers and failure to generate increased business through existing or new channel partner relationships; uncertainties related to continued success in sales growth and market share gains; failure to convert sales opportunities into definitive customer agreements; risks associated with successful implementation of multiple integrated software products and other product functionality; competition, particularly from larger companies with more resources than Proofpoint; risks related to new target markets, new product introductions and innovation and market acceptance thereof; the ability to attract and retain key personnel; potential changes in strategy; risks associated with management of growth; lengthy sales and implementation cycles, particularly in larger organizations; the time it takes new sales personnel to become fully productive; unforeseen delays in developing new technologies and the uncertain market acceptance of new products or features; technological changes that make Proofpoint's products and services less competitive; security breaches, which could affect our brand; the costs of litigation; the impact of changes in foreign currency exchange rates; the effect of general economic conditions, including as a result of specific economic risks in different geographies and among different industries; risks related to integrating the employees, customers and technologies of acquired businesses; assumption of unknown liabilities from acquisitions; ability to retain customers of acquired entities; and the other risk factors set forth from time to time in our filings with the SEC, including our Quarterly Report on Form 10-Q for the three months ended September 30, 2016, and the other reports we file with the SEC, copies of which are available free of charge at the SEC's website at www.sec.gov or upon request from our investor relations department.  All forward-looking statements herein reflect our opinions only as of the date of this release, and Proofpoint undertakes no obligation, and expressly disclaims any obligation, to update forward-looking statements herein in light of new information or future events.

Computational Guidance on Earnings Per Share Estimates

Accounting principles require that EPS be computed based on the weighted average shares outstanding ("basic"), and also assuming the issuance of potentially issuable shares (such as those subject to stock options, convertible notes, etc.) if those potentially issuable shares would reduce EPS ("diluted").

The number of shares related to options and similar instruments included in diluted EPS is based on the "Treasury Stock Method" prescribed in Financial Accounting Standards Board ("FASB") ASC Topic 260, Earnings Per Share ("FASB ASC Topic 260"). This method assumes a theoretical repurchase of shares using the proceeds of the respective stock option exercise at a price equal to the issuer's average stock price during the related earnings period. Accordingly, the number of shares includable in the calculation of diluted EPS in respect of stock options and similar instruments is dependent on this average stock price and will increase as the average stock price increases.

The number of shares includable in the calculation of diluted EPS in respect of convertible senior notes is based on the "If Converted" method prescribed in FASB ASC Topic 260. This method assumes the conversion or exchange of these securities for shares of common stock. In determining if convertible securities are dilutive, the interest savings (net of tax) subsequent to an assumed conversion are added back to net earnings. The shares related to a convertible security are included in diluted EPS only if EPS as otherwise calculated is greater than the interest savings, net of tax, divided by the shares issuable upon exercise or conversion of the instrument. Accordingly, the calculation of diluted EPS for these instruments is dependent on the level of net earnings. Each series of convertible securities is considered individually and in sequence, starting with the series having the lowest incremental earnings per share, to determine if its effect is dilutive or anti-dilutive.

Non-GAAP Financial Measures

We have provided in this release financial information that has not been prepared in accordance with GAAP. We use these non-GAAP financial measures internally in analyzing our financial results and believe they are useful to investors, as a supplement to GAAP measures, in evaluating our ongoing operational performance. We believe that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing our financial results with other companies in our industry, many of which present similar non-GAAP financial measures to investors. 

Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures below. As previously mentioned, a reconciliation of our non-GAAP financial measures to their most directly comparable GAAP measures has been provided in the financial statement tables included below in this press release.

Non-GAAP gross profit and gross margin. We define non-GAAP gross profit as GAAP gross profit, adjusted to exclude stock-based compensation expense and the amortization of intangibles associated with acquisitions. We define non-GAAP gross margin as non-GAAP gross profit divided by GAAP revenue. We consider these non-GAAP financial measures to be useful metrics for management and investors because they exclude the effect of non-cash charges that can fluctuate for Proofpoint, based on timing of equity award grants and the size, timing and purchase price allocation of acquisitions so that our management and investors can compare our recurring core business operating results over multiple periods. There are a number of limitations related to the use of non-GAAP gross profit and non-GAAP gross margin versus gross profit and gross margin, in each case, calculated in accordance with GAAP. For example, stock-based compensation has been and will continue to be for the foreseeable future a significant recurring expense in our business. Stock-based compensation is an important part of our employees' compensation and impacts their performance. In addition, the components of the costs that we exclude in our calculation of non-GAAP gross profit and non-GAAP gross margin may differ from the components that our peer companies exclude when they report their non-GAAP results.  Management compensates for these limitations by providing specific information regarding the GAAP amounts excluded from non-GAAP gross profit and non-GAAP gross margin and evaluating non-GAAP gross profit and non-GAAP gross margin together with gross profit and gross margin calculated in accordance with GAAP.

Non-GAAP operating loss. We define non-GAAP operating loss as operating loss, adjusted to exclude stock-based compensation expense and the amortization of intangibles and costs associated with acquisitions and litigation. Costs associated with acquisitions include legal, accounting, and other professional fees, as well as changes in the fair value of contingent consideration obligations. We consider this non-GAAP financial measure to be a useful metric for management and investors because they exclude the effect of stock-based compensation expense and the amortization of intangibles and costs associated with acquisitions and litigation so that our management and investors can compare our recurring core business operating results over multiple periods. There are a number of limitations related to the use of non-GAAP operating loss versus operating loss calculated in accordance with GAAP. For example, as noted above, non-GAAP operating loss excludes stock-based compensation expense. In addition, the components of the costs that we exclude in our calculation of non-GAAP operating loss may differ from the components that our peer companies exclude when they report their non-GAAP results of operations, and some of these items are cash-based. Management compensates for these limitations by providing specific information regarding the GAAP amounts excluded from non-GAAP operating loss and evaluating non-GAAP operating loss together with operating loss calculated in accordance with GAAP.

Non-GAAP net loss. We define non-GAAP net loss as net loss, adjusted to exclude stock-based compensation expense, amortization of intangibles, costs associated with acquisitions and litigation, non-cash interest expense related to the convertible debt discount and issuance costs for the convertible debt offering, and tax effects associated with these items. We consider this non-GAAP financial measure to be a useful metric for management and investors for the same reasons that we use non-GAAP operating loss. However, in order to provide a complete picture of our recurring core business operating results, we also exclude from non-GAAP net loss the tax effects associated with stock-based compensation and the amortization of intangibles and costs associated with acquisitions and litigation, and non-cash interest expense related to the convertible debt discount and issuance costs for the convertible debt offering.

Billings. We define billings as revenue recognized plus the change in deferred revenue from the beginning to the end of the period, but excluding additions to deferred revenue from acquisitions. We consider billings to be a useful metric for management and investors because billings drive deferred revenue, which is an important indicator of the health and visibility of our business, and has historically represented a majority of the quarterly revenue that we recognize. There are a number of limitations related to the use of billings versus revenue calculated in accordance with GAAP. Billings include amounts that have not yet been recognized as revenue, but exclude additions to deferred revenue from acquisitions. We may also calculate billings in a manner that is different from other companies that report similar financial measures. Management compensates for these limitations by providing specific information regarding GAAP revenue and evaluating billings together with revenues calculated in accordance with GAAP.

Adjusted EBITDA. We define adjusted EBITDA as net loss, adjusted to exclude: depreciation, amortization of intangibles, interest income (expense), net, provision for income taxes, stock-based compensation, acquisition- and litigation-related expense, other income (expense), net. We believe that the use of adjusted EBITDA is useful to investors and other users of our financial statements in evaluating our operating performance because it provides them with an additional tool to compare business performance across companies and across periods. We use adjusted EBITDA in conjunction with traditional GAAP operating performance measures as part of our overall assessment of our performance, for planning purposes, including the preparation of our annual operating budget, to evaluate the effectiveness of our business strategies and to communicate with our board of directors concerning our financial performance. We do not place undue reliance on adjusted EBITDA as our only measure of operating performance. Adjusted EBITDA should not be considered as a substitute for other measures of financial performance reported in accordance with GAAP. There are limitations to using this non-GAAP financial measure, including that other companies may calculate this measure differently than we do, that it does not reflect our capital expenditures or future requirements for capital expenditures and that it does not reflect changes in, or cash requirements for, our working capital and excluding some items that are cash based.

Free cash flow. We define free cash flow as net cash provided by operating activities minus capital expenditures. We consider free cash flow to be a liquidity measure that provides useful information to management and investors about the amount of cash generated by the business that, after the acquisition of property and equipment, can be used for strategic opportunities, including investing in our business, making strategic acquisitions, and strengthening the balance sheet. Analysis of free cash flow facilitates management's comparisons of our operating results to competitors' operating results. A limitation of using free cash flow versus the GAAP measure of net cash provided by operating activities as a means for evaluating our company is that free cash flow does not represent the total increase or decrease in the cash balance from operations for the period because it excludes cash used for capital expenditures during the period. Management compensates for this limitation by providing information about our capital expenditures on the face of the cash flow statement and in the "Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources" section of our quarterly and annual reports filed with the SEC.

 
Proofpoint, Inc.
Consolidated Statements of Operations
(In thousands, except per share amounts)
(Unaudited)
                     
                     
        Three Months Ended December 31,   Twelve Months Ended December 31,
          2016       2015       2016       2015  
Revenue:                    
Subscription       $ 104,082     $ 72,472     $ 365,960     $ 257,329  
Hardware and services         2,723       2,467       9,536       8,068  
Total revenue         106,805       74,939       375,496       265,397  
Cost of revenue: (1)(2)                    
Subscription         25,849       20,374       94,716       71,746  
Hardware and services         3,982       3,518       13,877       12,312  
Total cost of revenue         29,831       23,892       108,593       84,058  
Gross profit         76,974       51,047       266,903       181,339  
Operating expense: (1)(2)                    
Research and development         27,772       20,092       98,506       74,459  
Sales and marketing         54,550       41,174       201,204       148,414  
General and administrative         10,778       10,827       52,774       36,616  
Total operating expense         93,100       72,093       352,484       259,489  
Operating loss         (16,126 )     (21,046 )     (85,581 )     (78,150 )
Interest expense         (6,009 )     (5,912 )     (23,538 )     (18,000 )
Other expense, net         (575 )     (292 )     (1,103 )     (1,927 )
Loss before provision for income taxes         (22,710 )     (27,250 )     (110,222 )     (98,077 )
Provision for income taxes         (174 )     (142 )     (986 )     (635 )
Net loss       $ (22,884 )   $ (27,392 )   $ (111,208 )   $ (98,712 )
Net loss per share, basic and diluted       $ (0.54 )   $ (0.68 )   $ (2.66 )   $ (2.48 )
Weighted average shares outstanding, basic and diluted         42,616       40,531       41,859       39,787  
                     
(1) Includes stock‑based compensation expense as follows:                    
Cost of subscription revenue       $ 1,988     $ 1,408     $ 7,427     $ 5,028  
Cost of hardware and services revenue         374       324       1,494       1,098  
Research and development         6,844       5,110       24,342       20,672  
Sales and marketing         7,897       6,016       28,607       21,511  
General and administrative         4,439       3,379       16,826       11,785  
Total stock-based compensation expense       $ 21,542     $ 16,237     $ 78,696     $ 60,094  
(2) Includes intangible amortization expense as follows:                    
Cost of subscription revenue       $ 2,965     $ 2,165     $ 9,423     $ 7,079  
Research and development         15       22       60       91  
Sales and marketing         1,000       1,235       4,938       5,074  
General and administrative         -       -       -       12  
Total intangible amortization expense       $ 3,980     $ 3,422     $ 14,421     $ 12,256  
                     

 

Proofpoint, Inc.
Consolidated Balance Sheets
(In thousands, except per share amounts)
(Unaudited)
             
        December 31,   December 31,
          2016       2015  
Assets            
Current assets:            
Cash and cash equivalents       $ 345,426     $ 346,205  
Short-term investments         51,325       60,032  
Accounts receivable, net         72,951       54,522  
Inventory         598       485  
Deferred product costs         1,829       2,228  
Deferred commissions         21,168       19,314  
Prepaid expenses and other current assets         17,498       5,695  
Total current assets         510,795       488,481  
Property and equipment, net         52,523       34,501  
Deferred product costs         310       314  
Goodwill         167,270       133,769  
Intangible assets, net         61,708       41,330  
Long-term deferred commissions         4,496       3,488  
Other assets         4,558       3,733  
Total assets       $ 801,660     $ 705,616  
Liabilities and Stockholders’ Equity            
Current liabilities:            
Accounts payable       $ 15,297     $ 14,081  
Accrued liabilities         51,177       35,053  
Capital lease obligations         32       32  
Deferred rent         409       496  
Deferred revenue         259,109       182,195  
Total current liabilities         326,024       231,857  
Convertible senior notes         366,541       345,699  
Long-term capital lease obligations         91       123  
Long-term deferred rent         2,413       2,033  
Other long-term liabilities         9,008       1,188  
Long-term deferred revenue         53,072       41,531  
Total liabilities         757,149       622,431  
Stockholders’ equity            
Common stock, $0.0001 par value; 200,000 shares authorized; 43,015 and 40,840 shares issued and outstanding at December 31, 2016 and 2015, respectively         4       4  
Additional paid-in capital         513,622       441,104  
Accumulated other comprehensive loss         (7 )     (23 )
Accumulated deficit         (469,108 )     (357,900 )
Total stockholders’ equity         44,511       83,185  
Total liabilities and stockholders’ equity       $ 801,660     $ 705,616  
             

 

Proofpoint, Inc.
Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
                     
        Three Months Ended December 31,   Twelve Months Ended December 31,
          2016       2015       2016       2015  
Cash flows from operating activities                    
Net loss       $ (22,884 )   $ (27,392 )   $ (111,208 )   $ (98,712 )
Adjustments to reconcile net loss to net cash provided by operating activities:                    
Depreciation and amortization         8,839       6,960       31,552       24,900  
Loss on disposal of property and equipment         129       38       434       162  
Amortization of investment premiums, net of accretion of purchase discounts         (48 )     12       4       103  
Allowance (recovery) for doubtful accounts         52       27       17       (231 )
Stock‑based compensation         21,542       16,237       78,696       60,094  
Change in fair value of contingent consideration         (669 )     -       (669 )     -  
Amortization of debt issuance costs and accretion of debt discount         5,326       5,022       20,842       14,933  
Foreign currency transaction loss         593       240       852       1,657  
Changes in assets and liabilities:                    
Accounts receivable         (3,920 )     (16,084 )     (18,754 )     (12,811 )
Inventory         (168 )     353       (113 )     14  
Deferred products costs         (2 )     90       402       (388 )
Deferred commissions         (3,228 )     (3,983 )     (2,862 )     (7,742 )
Prepaid expenses         (191 )     181       (2,660 )     (1,829 )
Other current assets         (1,933 )     (519 )     (1,472 )     104  
Deferred income taxes         22       153       (1 )     509  
Long-term assets         911       2       959       47  
Accounts payable         1,365       4,633       4,271       2,460  
Accrued liabilities         3,465       (486 )     6,398       4,448  
Deferred rent         395       164       292       (165 )
Deferred revenue         31,642       22,570       87,255       58,951  
Net cash provided by operating activities         41,238       8,218       94,235       46,504  
Cash flows from investing activities                    
Proceeds from sales and maturities of short-term investments         20,343       4,597       123,405       39,056  
Purchase of short-term investments         (33,453 )     (16,459 )     (114,686 )     (64,537 )
Purchase of property and equipment         (8,880 )     (7,700 )     (34,407 )     (25,827 )
Payment to escrow account         -       -       (9,645 )     -  
Receipts from escrow account         260       -       260       -  
Acquisitions of business, net of cash acquired         (45,807 )     (11,499 )     (54,158 )     (51,553 )
Net cash used in investing activities         (67,537 )     (31,061 )     (89,231 )     (102,861 )
Cash flows from financing activities                    
Proceeds from issuance of common stock         6,633       6,702       21,779       18,583  
Withholding taxes related to restricted stock net share settlement         (8,573 )     (5,652 )     (25,588 )     (18,108 )
Payments of debt issuance costs         -       -       -       (371 )
Proceeds from issuance of convertible senior notes         -       -       -       223,790  
Repayments of equipment loans and capital lease obligations         (8 )     (7 )     (32 )     (706 )
Holdback payments for prior acquisitions         -       -       (1,397 )     -  
Net cash (used in) provided by financing activities         (1,948 )     1,043       (5,238 )     223,188  
Effect of exchange rate changes on cash and cash equivalents         (509 )     (166 )     (545 )     (963 )
Net (decrease) increase in cash and cash equivalents         (28,756 )     (21,966 )     (779 )     165,868  
Cash and cash equivalents                    
Beginning of period         374,182       368,171       346,205       180,337  
End of period       $ 345,426     $ 346,205     $ 345,426     $ 346,205  
                     

 

Reconciliation of Non-GAAP Measures
(In thousands, except per share amounts)
(Unaudited)
                     
          Three Months Ended       Twelve Months Ended  
          December 31,       December 31,  
          2016       2015       2016       2015  
                     
GAAP gross profit       $ 76,974     $ 51,047     $ 266,903     $ 181,339  
GAAP gross margin         72 %     68 %     71 %     68 %
Plus:                    
Stock-based compensation expense         2,362       1,732       8,921       6,126  
Intangible amortization expense         2,965       2,165       9,423       7,079  
Non-GAAP gross profit         82,301       54,944       285,247       194,544  
Non-GAAP gross margin         77 %     73 %     76 %     73 %
                     
GAAP operating loss         (16,126 )     (21,046 )     (85,581 )     (78,150 )
Plus:                    
Stock-based compensation expense         21,542       16,237       78,696       60,094  
Intangible amortization expense         3,980       3,422       14,421       12,256  
Acquisition-related expenses         494       360       1,080       911  
Litigation-related expenses         9       2,045       12,950       4,577  
Non-GAAP operating income (loss)         9,899       1,018       21,566       (312 )
                     
GAAP net loss         (22,884 )     (27,392 )     (111,208 )     (98,712 )
Plus:                    
Stock-based compensation expense         21,542       16,237       78,696       60,094  
Intangible amortization expense         3,980       3,422       14,421       12,256  
Acquisition-related expenses         494       360       1,080       911  
Litigation-related expenses         9       2,045       12,950       4,577  
Interest expense - debt discount and issuance costs         5,326       5,022       20,842       14,933  
Income tax benefit (expense)         26       (70 )     99       (181 )
Non-GAAP net income (loss)       $ 8,493     $ (376 )   $ 16,880     $ (6,122 )
Add interest expense of convertible senior notes, net of tax (1)         1,060       -       -       -  
Numerator for non-GAAP EPS calculation       $ 9,553     $ (376 )   $ 16,880     $ (6,122 )
Non-GAAP net income (loss) per share - diluted       $ 0.18     $ (0.01 )   $ 0.37     $ (0.15 )
                     
GAAP weighted-average shares used to compute net loss per share, diluted         42,616       40,531       41,859       39,787  
Dilutive effect of convertible senior notes (1)         7,989       -       -       -  
Dilutive effect of employee equity incentive plan awards (2)         3,802       -       3,908       -  
Non-GAAP weighted-average shares used to compute net income (loss) per share, diluted         54,407       40,531       45,767       39,787  
                     
(1) The Company uses the if-converted method to compute diluted earnings per share with respect to its convertible senior notes. There was no add-back of interest expense or additional dilutive shares related to the convertible senior notes where the effect was anti-dilutive.
(2) The Company uses the treasury method to compute the dilutive effect of employee equity incentive plan awards.
                     
                     
                     
Reconciliation of Net Loss to Adjusted EBITDA
(In thousands)
(Unaudited)
                     
          Three Months Ended       Twelve Months Ended  
          December 31,       December 31,  
          2016       2015       2016       2015  
                     
Net loss       $ (22,884 )   $ (27,392 )   $ (111,208 )   $ (98,712 )
Depreciation         4,859       3,537       17,131       12,644  
Amortization of intangible assets         3,980       3,422       14,421       12,256  
Interest expense         6,009       5,912       23,538       18,000  
Provision for income taxes         174       142       986       635  
EBITDA       $ (7,862 )   $ (14,379 )   $ (55,132 )   $ (55,177 )
                     
Stock-based compensation expense       $ 21,542     $ 16,237     $ 78,696     $ 60,094  
Acquisition-related expenses         494       360       1,080       911  
Litigation-related expenses         9       2,045       12,950       4,577  
Other expense, net         575       292       1,103       1,927  
Adjusted EBITDA       $ 14,758     $ 4,555     $ 38,697     $ 12,332  
                     
                     
                     
Reconciliation of Total Revenue to Billings
(In thousands)
(Unaudited)
                     
          Three Months Ended       Twelve Months Ended  
          December 31,       December 31,  
          2016       2015       2016       2015  
                     
Total revenue       $ 106,805     $ 74,939     $ 375,496     $ 265,397  
                     
Deferred revenue                    
Ending         312,181       223,726       312,181       223,726  
Beginning         280,539       199,756       223,726       162,675  
Net Change         31,642       23,970       88,455       61,051  
Less:                    
Deferred revenue contributed by acquisitions         -       (1,400 )     (1,200 )     (2,100 )
Billings       $ 138,447     $ 97,509     $ 462,751     $ 324,348  
                     

 

Reconciliation of GAAP Cash Flows from Operations to Free Cash Flows
(In thousands)
(Unaudited)
                     
          Three Months Ended       Twelve Months Ended  
          December 31,       December 31,  
          2016       2015       2016       2015  
                     
GAAP cash flows provided by operating activities       $ 41,238     $ 8,218     $ 94,235     $ 46,504  
Less:                    
Purchases of property and equipment         (8,880 )     (7,700 )     (34,407 )     (25,827 )
Non-GAAP free cash flows       $ 32,358     $ 518     $ 59,828     $ 20,677  
                     

 

Revenue by Solution
(In thousands)
(Unaudited)
                           
        Three Months Ended  
      December 31, 2016   September 30, 2016   June 30, 2016   March 31, 2016   December 31, 2015   September 30, 2015
                           
Protection and Advanced Threat     $ 78,698   $ 72,664   $ 64,797   $ 56,462   $ 53,544   $ 47,920
Archiving, Privacy and Governance       28,107     27,120     25,107     22,541     21,395     21,229
Total revenue     $ 106,805   $ 99,784   $ 89,904   $ 79,003   $ 74,939   $ 69,149
                           

 

Reconciliation of Non-GAAP Measures to Guidance
(In millions, except per share amount)
(Unaudited)
         
      Three Months Ending       Year Ending  
      March 31,       December 31,  
    2017   2017
         
GAAP net loss   $(31.6) - $(28.5)   $(121.4) - $(113.3)
Plus:        
Stock-based compensation expense   25.0 - 23.0   106.0- 100.0
Intangible amortization expense   4.2   16.4
Acquisition-related expenses   -   -
Litigation-related expenses   -   -
Interest expense - debt discount and issuance costs   5.4   22.1
Income tax expense   (0.0) - (0.1)   (0.1) - (0.2)
Non-GAAP net income   $3.0 - $4.0   $23.0 - $25.0
Add interest expense of convertible senior notes, net of tax (if dilutive)   1.1   4.2
Numerator for non-GAAP EPS calculation   $4.1 - $5.1   $27.2 - $29.2
Non-GAAP net income per share - diluted   $0.07 - $0.09   $0.49 - $0.52
Non-GAAP weighted-average shares used to compute net income per share, diluted   54.7   55.7
         
         
         
         
      Three Months Ending       Year Ending  
      March 31,       December 31,  
    2017   2017
         
GAAP cash flows provided by operating activities   $27.5 - $33.5   $135.0 - $147.0
Less:        
Purchases of property and equipment   12.5 - 13.5   40.0 - 42.0
Non-GAAP free cash flows   $15.0 - $20.0   $95.0 - $105.0
         

Media Contact Kristy Campbell Proofpoint, Inc. 408-517-4710 kcampbell@proofpoint.com Investor Contacts Jason Starr Proofpoint, Inc. 408-585-4351 jstarr@proofpoint.com Seth Potter ICR for Proofpoint, Inc. 646-277-1230 seth.potter@icrinc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Madrigal Faces Legal Scrutiny Amid Whistleblower Claims

Updated Category News Views 233

The Storm Brewing Over Madrigal Pharmaceuticals Well, folks, here we are smack dab in the middle of another roller-coaster ride in the biotech sector, and it ain't pretty. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is in hot water with some serious allegations thrown their way. The company is now under investigation by Kessler Topaz Meltzer & Check, LLP, a top-notch...

Continue Reading
Key Players Depart No Makeup Makeup Amid Rapid Success

Updated Category News Views 214

Change is afoot in the world of beauty. No Makeup Makeup, a brand that's managed to carve out a sizable niche, recently bid farewell to two of its main architects: Kim Wileman and Shauna Lahiri. These women didn't just steer the ship; they built the damn thing. Kicking Off the No Makeup Revolution Wileman and Lahiri were the pistons firing away at No Makeup Makeup, a...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 212

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Koppers Faces Investigation: Investors Cautious Amid Probe

Updated Category News Views 211

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

Continue Reading
DraftKings Faces Revenue Cutback; Legal Probe Begins

Updated Category News Views 190

DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...

Continue Reading
Blue Owl Tech Faces Lawsuit Post-44% Share Dive

Updated Category News Views 59

The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....

Continue Reading
Tenax Therapeutics Faces Legal Heat After Stock Plunge

Updated Category News Views 133

Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 151

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 82

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 206

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading

Top 5 Most Recently Viewed Articles

UGO Token Revolutionizes Trading with Innovative Launch

Updated Category News Views 216

UGO Token Launching on PancakeSwap UGO, the latest addition to the innovative ecosystem featuring Gooo and WeGo, is set to make waves in the trading sphere with its exceptional Hybrid Token Model. This new framework emphasizes fairness, sustainability, and real-world utility, offering an exciting opportunity for both everyday traders and crypto enthusiasts alike. What...

Continue Reading
Empyrean Anaheim Faces Legal Battle Over Wage Practices

Updated Category News Views 33

California Labor Law Clashes in the Spotlight When a lawsuit against a big name like Empyrean Anaheim Resort hits headlines, it raises eyebrows. Folks, we're talking about a class action filed in California, no less—a state with some of the toughest labor laws around. The legal eagles at Blumenthal Nordrehaug Bhowmik De Blouw LLP are on the case, claiming Empyrean...

Continue Reading
China's Diplomatic Efforts to Stabilize Middle East Oil Market

Updated Category News Views 174

China's Role in Mediating Middle Eastern Conflicts As the world’s second-largest oil consumer, China is stepping into a critical role by urging Israel and Iran to de-escalate their ongoing tensions. In this complex geopolitical landscape, China's top diplomat, Wang Yi, took proactive measures through separate phone calls with officials from both nations, advocating for...

Continue Reading
Jason Wyatt: Transforming Leadership and Achieving Success

Updated Category News Views 524

Jason Wyatt Recognized for His Exceptional Leadership In a remarkable acknowledgment by The Inner Circle, Jason Wyatt, an esteemed CEO, is honored as an Inner Circle Lifetime member. This recognition is a testament to his significant contributions to Transforming Leadership and Driving Success Through Innovative Coaching. Jason Wyatt's Innovative Approach to Leadership As...

Continue Reading
Terray Therapeutics Secures $120M Series B for Drug Innovation

Updated Category News Views 293

Terray Therapeutics Secures Significant Series B Investment Terray Therapeutics, a dynamic player in the biotechnology sector, has successfully closed an oversubscribed Series B funding round, raising $120 million. This investment aims to advance the company's unique generative AI pipeline for small molecule therapeutics, enhancing their capabilities to bring innovative...

Continue Reading